These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38416704)

  • 1. Risk factors contributing to infection with SARS-CoV-2 are modulated by sex.
    Lecona OA; Arroyo-Valerio AG; Bueno-Hernández N; Carrillo-Ruíz JD; Ruelas L; Márquez-Franco R; Aguado-García A; Barrón EV; Escobedo G; Ibarra-Coronado E; Olguín-Rodríguez PV; Barajas-Martínez A; Rivera AL; Fossion R
    PLoS One; 2024; 19(2):e0297901. PubMed ID: 38416704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled, double-blind, randomized trial to assess the efficacy and safety of hydroxychloroquine chemoprophylaxis in SARS CoV2 infection in healthcare personnel in the hospital setting: A structured summary of a study protocol for a randomised controlled trial.
    Cuadrado-Lavín A; Olmos JM; Cifrian JM; Gimenez T; Gandarillas MA; García-Saiz M; Rebollo MH; Martínez-Taboada V; López-Hoyos M; Fariñas MC; Crespo J
    Trials; 2020 Jun; 21(1):472. PubMed ID: 32493494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-exposure prophylaxis with hydroxychloroquine for high-risk healthcare workers during the COVID-19 pandemic: A structured summary of a study protocol for a multicentre, double-blind randomized controlled trial.
    Grau-Pujol B; Camprubí D; Marti-Soler H; Fernández-Pardos M; Guinovart C; Muñoz J
    Trials; 2020 Jul; 21(1):688. PubMed ID: 32727613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decline in Sars-CoV-2 antibodies over 6-month follow-up in obstetrical healthcare workers.
    Kiefer MK; Allen KD; Russo JR; Ma'ayeh M; Gee SE; Kniss D; Cackovic M; Costantine MM; Rood KM
    Am J Reprod Immunol; 2021 Dec; 86(6):e13490. PubMed ID: 34358389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2-specific antibody detection in healthcare workers in Germany with direct contact to COVID-19 patients.
    Korth J; Wilde B; Dolff S; Anastasiou OE; Krawczyk A; Jahn M; Cordes S; Ross B; Esser S; Lindemann M; Kribben A; Dittmer U; Witzke O; Herrmann A
    J Clin Virol; 2020 Jul; 128():104437. PubMed ID: 32434708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of Health Care and Hospital Worker SARS-CoV-2 IgG Antibody in a Pediatric Hospital.
    Tokareva Y; Englund JA; Dickerson JA; Brown JC; Zerr DM; Walter E; Tsogoo A; Cappetto K; Valdez Gonzalez J; Strelitz B; Klein EJ
    Hosp Pediatr; 2021 Mar; 11(3):e48-e53. PubMed ID: 33361400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of SARS-CoV-2 antibodies in pediatric healthcare workers.
    Morris CR; Sullivan P; Mantus G; Sanchez T; Zlotorzynska M; Hanberry B; Iyer S; Heilman S; Camacho-Gonzalez A; Figueroa J; Manoranjithan S; Leake D; Mendis R; Cleeton R; Chen C; Krieger R; Bush P; Hughes T; Little WK; Suthar MS; Wrammert J; Vos MB
    Int J Infect Dis; 2021 Apr; 105():474-481. PubMed ID: 33722686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in Japan.
    Yazaki S; Yoshida T; Kojima Y; Yagishita S; Nakahama H; Okinaka K; Matsushita H; Shiotsuka M; Kobayashi O; Iwata S; Narita Y; Ohba A; Takahashi M; Iwasa S; Kobayashi K; Ohe Y; Yoshida T; Hamada A; Doi T; Yamamoto N
    JAMA Oncol; 2021 Aug; 7(8):1141-1148. PubMed ID: 34047762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of and Risk Factors Associated With SARS-CoV-2 Infection in Health Care Workers During the Early COVID-19 Pandemic in Italy.
    Poletti P; Tirani M; Cereda D; Guzzetta G; Trentini F; Marziano V; Toso C; Piatti A; Piccarreta R; Melegaro A; Andreassi A; Gramegna M; Ajelli M; Merler S
    JAMA Netw Open; 2021 Jul; 4(7):e2115699. PubMed ID: 34228126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Features of antibody responses after SARS-COV-2 infection in healthcare workers in the first wave of COVID-19 pandemic in Mexico City.
    Thompson-Bonilla MDR; León JA; Cárdenas-Turrent MB; Peña-Thompson A; Hanessian-De la Garza D; Zavala-Vega S; Xicohtencatl-Cortes J; Ochoa SA; Cruz-Córdova A; Arellano-Galindo J
    J Int Med Res; 2022 Jul; 50(7):3000605221099458. PubMed ID: 35879824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of humoral immune response over 17 months of COVID-19 pandemic in a large cohort of healthcare workers in Spain: the ProHEpiC-19 study.
    Violán C; Torán-Monserrat P; Quirant B; Lamonja-Vicente N; Carrasco-Ribelles LA; Chacón C; Manresa-Dominguez JM; Ramos-Roure F; Dacosta-Aguayo R; Palacios-Fernández C; Roso-Llorach A; Pujol A; Ouchi D; Monteagudo M; Montero-Alia P; Garcia-Sierra R; Arméstar F; Doladé M; Prat N; Bonet JM; Clotet B; Blanco I; Boigues-Pons M; Moreno-Millán N; Prado JG; Cáceres EMM;
    BMC Infect Dis; 2022 Sep; 22(1):721. PubMed ID: 36057544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study.
    Letizia AG; Ge Y; Vangeti S; Goforth C; Weir DL; Kuzmina NA; Balinsky CA; Chen HW; Ewing D; Soares-Schanoski A; George MC; Graham WD; Jones F; Bharaj P; Lizewski RA; Lizewski SE; Marayag J; Marjanovic N; Miller CM; Mofsowitz S; Nair VD; Nunez E; Parent DM; Porter CK; Santa Ana E; Schilling M; Stadlbauer D; Sugiharto VA; Termini M; Sun P; Tracy RP; Krammer F; Bukreyev A; Ramos I; Sealfon SC
    Lancet Respir Med; 2021 Jul; 9(7):712-720. PubMed ID: 33865504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and risk factors of SARS-CoV-2 infection among workers in a public health laboratory in Tunisia.
    Kharroubi G; Cherif I; Ghawar W; Dhaouadi N; Yazidi R; Chaabane S; Snoussi MA; Salem S; Ben Hammouda W; Ben Hammouda S; Gharbi A; Bel Haj Hmida N; Rourou S; Dellagi K; Barbouche MR; Benabdessalem C; Ben Ahmed M; Bettaieb J
    Arch Virol; 2023 Jan; 168(2):69. PubMed ID: 36658402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Fox T; Geppert J; Dinnes J; Scandrett K; Bigio J; Sulis G; Hettiarachchi D; Mathangasinghe Y; Weeratunga P; Wickramasinghe D; Bergman H; Buckley BS; Probyn K; Sguassero Y; Davenport C; Cunningham J; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Struyf T; Van den Bruel A; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013652. PubMed ID: 36394900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demographic and clinical characteristics associated with variations in antibody response to BNT162b2 COVID-19 vaccination among healthcare workers at an academic medical centre: a longitudinal cohort analysis.
    Ebinger JE; Joung S; Liu Y; Wu M; Weber B; Claggett B; Botting PG; Sun N; Driver M; Kao YH; Khuu B; Wynter T; Nguyen TT; Alotaibi M; Prostko JC; Frias EC; Stewart JL; Goodridge HS; Chen P; Jordan SC; Jain M; Sharma S; Fert-Bober J; Van Eyk JE; Minissian MB; Arditi M; Melmed GY; Braun JG; McGovern DPB; Cheng S; Sobhani K
    BMJ Open; 2022 May; 12(5):e059994. PubMed ID: 35613792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of SARS-CoV-2 re-infection in anti-nucleocapsid IgG-positive healthcare workers: a prospective cohort study.
    Mehboob S; Rehman A; Haq M; Rajab H; Haq M; Haq H; Ahmad J; Ahmad S; Abbas M; Anwar S; Haq N
    Ir J Med Sci; 2023 Apr; 192(2):915-918. PubMed ID: 35412213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No neutralizing effect of pre-existing tick-borne encephalitis virus antibodies against severe acute respiratory syndrome coronavirus-2: a prospective healthcare worker study.
    Kohler P; Jonsdottir HR; Risch L; Vernazza P; Ackermann-Gäumann R; Kahlert CR
    Sci Rep; 2021 Dec; 11(1):24198. PubMed ID: 34921220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Work at inpatient care units is associated with an increased risk of SARS-CoV-2 infection; a cross-sectional study of 8679 healthcare workers in Sweden.
    Lidström AK; Sund F; Albinsson B; Lindbäck J; Westman G
    Ups J Med Sci; 2020 Nov; 125(4):305-310. PubMed ID: 32684119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 infection rates of antibody-positive compared with antibody-negative health-care workers in England: a large, multicentre, prospective cohort study (SIREN).
    Hall VJ; Foulkes S; Charlett A; Atti A; Monk EJM; Simmons R; Wellington E; Cole MJ; Saei A; Oguti B; Munro K; Wallace S; Kirwan PD; Shrotri M; Vusirikala A; Rokadiya S; Kall M; Zambon M; Ramsay M; Brooks T; Brown CS; Chand MA; Hopkins S;
    Lancet; 2021 Apr; 397(10283):1459-1469. PubMed ID: 33844963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.